775 related articles for article (PubMed ID: 21768580)
1. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA
Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580
[TBL] [Abstract][Full Text] [Related]
2. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
[TBL] [Abstract][Full Text] [Related]
3. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
Chen YE; Kao SS; Chung RH
PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A; Sadeghi S; Kattan MW; Meropol NJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
Health Technol Assess; 2014 Sep; 18(58):1-406. PubMed ID: 25244061
[TBL] [Abstract][Full Text] [Related]
7. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.
Mvundura M; Grosse SD; Hampel H; Palomaki GE
Genet Med; 2010 Feb; 12(2):93-104. PubMed ID: 20084010
[TBL] [Abstract][Full Text] [Related]
9. Testing women with endometrial cancer to detect Lynch syndrome.
Kwon JS; Scott JL; Gilks CB; Daniels MS; Sun CC; Lu KH
J Clin Oncol; 2011 Jun; 29(16):2247-52. PubMed ID: 21537049
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
Snowsill TM; Ryan NAJ; Crosbie EJ; Frayling IM; Evans DG; Hyde CJ
PLoS One; 2019; 14(8):e0221419. PubMed ID: 31469860
[TBL] [Abstract][Full Text] [Related]
11. Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.
Wang G; Kuppermann M; Kim B; Phillips KA; Ladabaum U
Am J Manag Care; 2012 May; 18(5):e179-85. PubMed ID: 22694112
[TBL] [Abstract][Full Text] [Related]
12. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.
Ramsey SD; Clarke L; Etzioni R; Higashi M; Berry K; Urban N
Ann Intern Med; 2001 Oct; 135(8 Pt 1):577-88. PubMed ID: 11601929
[TBL] [Abstract][Full Text] [Related]
14. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
15. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2009 Jan; 11(1):35-41. PubMed ID: 19125126
[TBL] [Abstract][Full Text] [Related]
16. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
[TBL] [Abstract][Full Text] [Related]
17. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of genetic screening for Lynch syndrome in Germany.
Severin F; Stollenwerk B; Holinski-Feder E; Meyer E; Heinemann V; Giessen-Jung C; Rogowski W
Genet Med; 2015 Oct; 17(10):765-73. PubMed ID: 25569434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
